“3 “Strong Buy” Healthcare Stocks With Major Catalysts Approaching”
October 5, 2020
“Kala Pharmaceuticals (KALA)…
In general, other analysts echo Moussatos’ sentiment. 4 Buys and 1 Hold add up to a Strong Buy consensus rating. With an average price target of $20.80, the upside potential comes in at 173%…
Revance Therapeutics (RVNC)…
Are other analysts in agreement? They are. Only Buy ratings, 5 to be exact, have been issued in the last three months. Therefore, the message is clear: RVNC is a Strong Buy. Given the $34.20 average price target, shares could surge 38% in the next year…
Rhythm Pharmaceuticals (RYTM)…
Judging by the consensus breakdown, opinions are anything but mixed. With 4 Buys and no Holds or Sells assigned in the last three months, the word on the Street is that RYTM is a Strong Buy. At $38.67, the average price target implies 75% upside potential…”
https://finance.yahoo.com/news/3-strong-buy-healthcare-stocks-141549117.html